CIK 0001534120
- Non-accelerated filer
- Smaller reporting company
Avalo Therapeutics, Inc.
Sign in to watch- Ticker
- AVTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 450705648
- Phone
- +1 410-522-8707
- Business address
- 1500 LIBERTY RIDGE DRIVE, SUITE 321, WAYNE, PA, 19087
- Former names
- Cerecor Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $395,474
- in 3 filings, $395K under 10b5-1 plans
Net −$395,474. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-08-19 | ARMISTICE CAPITAL, LLC Director | Purchase | +473 | $3.50 | $2K | 18,439,644 |
| 2019-08-19 | ARMISTICE CAPITAL, LLC Director | Purchase | +0 | 18,439,644 | ||
| 2019-08-19 | ARMISTICE CAPITAL, LLC Director | Purchase | +1,825 | $3.63 | $7K | 18,441,469 |
| 2019-08-19 | ARMISTICE CAPITAL, LLC Director | Purchase | +0 | 18,441,469 | ||
| 2019-08-16 | ARMISTICE CAPITAL, LLC Director | Purchase | +9,886 | $3.43 | $34K | 18,439,171 |
| 2019-08-16 | ARMISTICE CAPITAL, LLC Director | Purchase | +0 | 18,439,171 | ||
| 2019-08-14 | ARMISTICE CAPITAL, LLC Director | Purchase | +56,842 | $3.37 | $192K | 400,000 |
| 2019-08-13 | ARMISTICE CAPITAL, LLC Director | Purchase | +29,188 | $3.30 | $96K | 343,158 |
| 2019-08-12 | ARMISTICE CAPITAL, LLC Director | Purchase | +13,970 | $3.20 | $45K | 313,970 |
| 2019-08-07 | Schmidt Keith Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2019-08-07 | Persson Magnus Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2019-08-07 | Hacksell Uli Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2019-08-07 | Gutry Phil Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2019-08-07 | Greenleaf Peter Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2019-07-16 | Calias Pericles Chief Scientific Officer | Shares withheld for taxes | −3,246 | $4.90 | $16K | 49,216 |
| 2019-06-28 | Pedder Simon Executive Chairman of the Bd | Grant or award · Stock Option (Right to Buy) | +117 | 117 | ||
| 2019-06-28 | Persson Magnus Director | Grant or award · Stock Option (Right to Buy) | +2,636 | 2,636 | ||
| 2019-06-28 | Hacksell Uli Director | Grant or award · Stock Option (Right to Buy) | +1,172 | 1,172 | ||
| 2019-06-28 | Gutry Phil Director | Grant or award · Stock Option (Right to Buy) | +2,323 | 2,323 | ||
| 2019-06-11 | Schmidt Keith Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 |
Page 24 of 25 · 500 trades